Luckett 2015.
Study characteristics | ||
Methods | Retrospective cohort study | |
Participants | 56 people with HIV and PDH | |
Interventions | ITRA/VORI/POSA (24 participants) AmB (32 participants) |
|
Outcomes | Overall and histoplasmosis‐related mortality, relapse, and treatment failure | |
Age | Mean 42 (range 26–74) years | |
Setting | USA | |
Disease severity | Mild to severe | |
Notes | Death not reported by treatment regimen Triazole failure: 4/24 participants |